The Association of Clinical Research Organizations (ACRO) is lead by a distinguished team of business, drug development and technology experts that comprise ACRO’s Board of Directors. Our Board of Directors is dedicated to advocating on behalf of safe, ethical clinical trials that protect patients and ensure high-quality results.
All Regular ACRO members maintain a seat on our Board of Directors. In addition, our Board’s Executive Committee is made up of the current ACRO Chair, Vice-Chair, and the immediate Past-Chair.
Board of Directors
Jackie Kent
Executive Industry Advisor, Medidata Solutions
Paul Kirchgraber
ACRO Chair & CEO, Labcorp Drug Development
Steve Cutler
CEO, ICON
Michael Brooks
Chief Development Officer & Global Head Clinical Development Solutions, Syneos Health
Cynthia Verst
President, R&DS Design & Delivery Innovation, IQVIA
Lisa Moneymaker
Chief Technology & Product Officer, Saama Technologies
Henry McNamara
ACRO Vice-Chair & SVP & GM, Oracle Health Sciences
Scott Connor
Chief Marketing Officer, Signant Health
Peyton Howell
Chief Operating & Growth Officer, Parexel
Catherine Gregor
Chief Clinical Trial Officer, Florence Healthcare
Karen Kaucic
Chief Medical Officer, PPD Clinical Research, Thermo Fisher Scientific
Chris Fikry
President & CEO, Clario
Jim Reilly
Vice President, R&D Strategy, Veeva Systems
Become and ACRO Member and add your voice.
ACRO Staff
Working together with ACRO’s member companies, our staff is committed to leveraging their collective experience in public policy, clinical research, communications and government relations to advance ACRO’s mission on behalf of our industry.
Doug Peddicord
Executive Director
Karen Noonan
Senior Vice President, Global Regulatory Policy
Anina Adelfio
Chief Operating Officer
Sophia McLeod
Director of Government Relations
Aislinn Quinn
Membership and Communications Coordinator